Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received an average recommendation of “Moderate Buy” from the ten ratings firms that are presently covering the firm, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $79.67.

Several research analysts recently issued reports on ACHC shares. KeyCorp began coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, November 22nd. Royal Bank of Canada reduced their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. Finally, Barclays cut their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $40.63 on Monday. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77. The stock’s 50-day moving average price is $50.46 and its 200 day moving average price is $63.52. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market capitalization of $3.77 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.80 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter in the prior year, the business earned $0.91 earnings per share. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, equities research analysts forecast that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently bought and sold shares of the stock. Wellington Management Group LLP lifted its position in shares of Acadia Healthcare by 12.2% in the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after acquiring an additional 1,266,384 shares in the last quarter. William Blair Investment Management LLC boosted its stake in shares of Acadia Healthcare by 20.7% during the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after purchasing an additional 604,070 shares during the last quarter. State Street Corp grew its holdings in shares of Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after buying an additional 95,613 shares in the last quarter. Point72 Asset Management L.P. raised its position in shares of Acadia Healthcare by 0.5% in the third quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock valued at $144,753,000 after buying an additional 12,470 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Acadia Healthcare by 0.9% during the third quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after buying an additional 14,197 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.